HIM
CLSD

Hillhouse Investment Management’s Clearside Biomedical CLSD Stock Holding History

Hillhouse Investment Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-62,947
Closed -$6.61M – 52
2017
Q4 		$6.61M Buy
62,947
+2,947
+5% +$316K 0.11% 39
2017
Q3 		$7.87M Hold
60,000
– – 0.13% 41
2017
Q2 		$8.2M Buy
60,000
+3,007
+5% +$361K 0.13% 41
2017
Q1 		$6.79M Buy
56,993
+16,993
+42% +$2.01M 0.13% 38
2016
Q4 		$5.36M Hold
40,000
– – 0.12% 26
2016
Q3 		$10.4M Hold
40,000
– – 0.21% 24
2016
Q2 		$4.21M Buy
+40,000
New +$4.19M 0.11% 20

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Hillhouse Investment Management's CLSD Position: Q1 2018 in Review

Hillhouse Investment Management sold out of Clearside Biomedical (CLSD) in Q1 2018, closing a stake of 62,947 shares — an estimated $6.61M sold.

Hillhouse Investment Management first reported a position in CLSD in Q2 2016 and held it in 7 quarters. The position peaked at $10.4M in Q3 2016. 79 funds tracked by Wall St. Rank hold CLSD as of Q1 2018.

  • Hillhouse Investment Management reported no remaining Clearside Biomedical position as of Q1 2018 after selling out during the quarter.
  • Hillhouse Investment Management sold 62,947 Clearside Biomedical shares in Q1 2018, an estimated $6.61M.
  • Hillhouse Investment Management first reported a position in Clearside Biomedical in Q2 2016 and held it in 7 quarters.
  • Hillhouse Investment Management's Clearside Biomedical position peaked at $10.4M in Q3 2016.
  • 79 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2018.

Based on Hillhouse Investment Management's 13F filing for Q1 2018, filed 15 May 2018.